Target intelligence / Profile preview

REX1, RNA exonuclease 1 homolog (S. cerevisiae)-like 7, pseudogene (REXO1L7P)

Target: REXO1L7P
Molecular classification: Other (Pseudogene)

Overview

REXO1L7P is classified as a pseudogene corresponding to "REX1, RNA exonuclease 1 homolog (S. cerevisiae)-like 7" in humans. Pseudogenes like REXO1L7P resemble protein-coding genes (in this case, the REXO1 gene family) but are not transcribed into functional protein products and therefore do not have known biological or disease-related roles[5]. This gene is not considered a drug target, nor does it have established therapeutic, biomarker, or safety functions.

Other names: REXO1L7PREX1, RNA exonuclease 1 homolog-like 7

Beyond the preview

Go deeper on REX1, RNA exonuclease 1 homolog (S. cerevisiae)-like 7, pseudogene (REXO1L7P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on REX1, RNA exonuclease 1 homolog (S. cerevisiae)-like 7, pseudogene (REXO1L7P).

Explore the full profile